期刊文献+

肝硬化腹水合并低钠血症146例临床分析 被引量:3

下载PDF
导出
摘要 目的探讨肝硬化腹水合并低钠血症的临床意义和对策。方法分析我院2003年1月—2006年12月收治的146例肝硬化腹水并发低钠血症的并发症、治疗过程、预后。结果轻、中、重度低钠血症的病死率分别为7.7%,16.7%和71.4%,肝性脑病的发生率分别为5.8%,9.1%和42.9%,肝肾综合征的发生率分别为1.9%,22.7%和64.3%。结论低钠血症在一定程度上反映预后恶劣,适度补钠有利于减少腹水和改善预后。
作者 黄宇 黄驰
出处 《现代中西医结合杂志》 CAS 2009年第3期266-267,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

二级参考文献20

  • 1赵杰强,朱安今.肝硬变腹水并低钠血症研究概况[J].传染病信息,1998,11(1):8-9. 被引量:4
  • 2刘颖翰,张舂兰,赵旭春.加强对肝硬化腹水低钠血症的认识[J].肝脏,2005,10(2):154-154. 被引量:10
  • 3Arroyo V, Gines P, Gerbes AL, et al. Deflnition and diagnostic criteria of refractory ascites and hepatorenal syndrorne in cirrhosis[J]. Hepatology, 1996,23:164.
  • 4Decaux G.Difference is solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985[].Journal of Laboratory and Clinical Medicine.2001
  • 5Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis[].Journal of Hepatology.2000
  • 6Gines P,Jimenez W.Aquaretic agent: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
  • 7Gines P,Jimenez W.Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
  • 8Bosch-Marce M,Jimenez W,Angeli P,et al.Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention[].Gastroenterology.1995
  • 9Bosch-Marce M,Poo JL,Jimenez W,et al.Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention[].Journal of Pharmacology and Experimental Therapeutics.1999
  • 10Borroni G,Maggi A,Sangiovanni A,et al.Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[].Digestive and Liver Disease.2000

共引文献104

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部